Mind over migraine: brain network may explain why some expect side effects
NCT ID NCT07720895
First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time
Summary
This study investigates whether changes in a brain network called the default mode network (DMN) are linked to the nocebo effect — experiencing side effects from negative expectations rather than from a treatment itself. Researchers will use functional MRI to scan the brains of 40 adults with migraine before and after a nocebo challenge, where some participants receive a saline infusion or verbal suggestion that they might feel numbness. The goal is to understand why some people are more susceptible to nocebo responses, which could lead to better communication and treatment adherence in migraine care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If this study identifies brain patterns linked to nocebo responses, it could help doctors predict who is at risk and improve communication about migraine treatments.
- What could go wrong
- This is a small, exploratory study with only 36 participants. The findings may not apply to all people with migraine, and larger studies are needed to confirm any results.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
1st Neurogy Department, Aeginition Hospital, National and Kapodistrian Hospital
Athens, 11528, Greece
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- The eyes as a window to the brain: can a simple scan monitor MS, Alzheimer's, and Parkinson's?
- Experimental migraine drug JS010 takes first step in human safety trial
- Scientists probe shared pain pathways in endometriosis and migraine
- Brain scans and heat tests may predict migraine in teens
- Could a simple diary ease the burden of migraine?
- Psilocybin's brain effects in migraine under the microscope